Jiangsu Hengrui Medicine
600276.SS
#529
Rank
NZ$69.74 B
Marketcap
$10.93
Share price
0.02%
Change (1 day)
22.79%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$1.01 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total liabilities are NZ$1.01 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Jiangsu Hengrui Medicine - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$0.90 B6.05%
2021-12-31NZ$0.84 B1.32%
2020-12-31NZ$0.83 B50.5%
2019-12-31NZ$0.55 B-0.72%
2018-12-31NZ$0.56 B23.59%
2017-12-31NZ$0.45 B49.91%
2016-12-31NZ$0.30 B17.87%
2015-12-31NZ$0.25 B33.51%
2014-12-31NZ$0.19 B69.46%
2013-12-31NZ$0.11 B29.35%
2012-12-31NZ$87.73 M-2.07%
2011-12-31NZ$89.59 M8.61%
2010-12-31NZ$82.48 M22.58%
2009-12-31NZ$67.29 M15.73%
2008-12-31NZ$58.14 M-19.29%
2007-12-31NZ$72.05 M97.06%
2006-12-31NZ$36.56 M13.85%
2005-12-31NZ$32.11 M-26.38%
2004-12-31NZ$43.62 M-57.17%
2003-12-31NZ$0.10 B11.81%
2002-12-31NZ$91.09 M-13.28%
2001-12-31NZ$0.10 B